MedTrace Logo

Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris

NCT04442919 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2024-03-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate differences in the pharmacokinetics and pharmacodynamics of ticagrelor and its active metabolite in patients who received ticagrelor followed with methoxyflurane versus ticagrelor followed with morphine or ticagrelor alone due to unstable angina pectoris

Conditions

  • Unstable Angina

Interventions

DRUG

Ticagrelor followed with Methoxyflurane

patients who received ticagrelor followed with inhaled methoxyflurane due to unstable angina

DRUG

Ticagrelor followed with Morphine

patients who received ticagrelor followed with intravenous morphine due to unstable angina

DRUG

Ticagrelor alone

patients who received ticagrelor without any analgesia due to unstable angina

Sponsors & Collaborators

  • Collegium Medicum w Bydgoszczy

    lead OTHER

Principal Investigators

  • Jacek Kubica, Professor · Collegium Medicum w Bydgoszczy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2024-01-31
Completion
2024-02-29

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04442919 on ClinicalTrials.gov